Recently, the U.S. Food and Drug Administration (FDA) has approved Carvykti, a chimeric antigen receptor (CAR) T-cell therapy product jointly developed by Legend Biotech and Johnson & Johnson, for the treatment of relapsed/refractory multiple myeloma. もっと見る ›
Cyagen recently hosted a live webinar covering the generation of genomically humanized mouse models for applications in preclinical research. Herein, we offer an extremely brief overview of the presentation and provide Dr. Ouyang’s personal responses to all the questions submitted during the webinar session. もっと見る ›
The production and preparation of rAAV is a key and difficult point in gene therapy, because the packaging system and purification method of rAAV will influence the infection efficiency and the expression efficiency of the target gene, and ultimately affect the results. もっと見る ›
Genes play a highly significant role in the pathogenesis of eye diseases, some of which are highly prevalent in children and adults. もっと見る ›
SYNGAP1 (Synaptic Ras GTPase Activating Protein 1) is a Protein Coding gene. The SYNGAP1 gene is located on Chromosome 6 and is responsible for producing the SynGAP protein. もっと見る ›
Lentiviruses (LVs) are one of the commonly used delivery vectors for cell and gene therapy, which have been successfully applied to the preparation of CAR-T cells. もっと見る ›
CEP290 (Centrosomal Protein 290) is a Protein Coding gene, encodes a centrosomal protein involved in ciliary assembly and ciliary trafficking. もっと見る ›
Read on to explore why rodent groups barber themselves and each other, the ways this may be prevented, and some common questions and answers about this issue. もっと見る ›
In February 2022, the Rare Diseases Data Center (RDDC) was officially released to the international research community. もっと見る ›
In recent years, the application of CRISPR-mediated gene editing in iPS cells has attracted more and more attention. もっと見る ›